MSCV h c-MYC IRES GFP Citations (14)
Originally described in: Cleveland lab plasmidsUnpublished
Articles Citing MSCV h c-MYC IRES GFP
| Articles |
|---|
| Generation of induced pluripotent stem cell lines from human fibroblasts via retroviral gene transfer. Miller JD, Schlaeger TM. Methods Mol Biol. 2011;767:55-65. doi: 10.1007/978-1-61779-201-4_5. PubMed |
| Reprogramming human somatic cells into induced pluripotent stem cells (iPSCs) using retroviral vector with GFP. Kim KY, Hysolli E, Park IH. J Vis Exp. 2012 Apr 3;(62). pii: 3804. doi: 10.3791/3804. PubMed |
| A novel rapid-onset high-penetrance plasmacytoma mouse model driven by deregulation of cMYC cooperating with KRAS12V in BALB/c mice. Hu Y, Zheng M, Gali R, Tian Z, Topal Gorgun G, Munshi NC, Mitsiades CS, Anderson KC. Blood Cancer J. 2013 Nov 1;3:e156. doi: 10.1038/bcj.2013.53. PubMed |
| Flavaglines target primitive leukemia cells and enhance anti-leukemia drug activity. Callahan KP, Minhajuddin M, Corbett C, Lagadinou ED, Rossi RM, Grose V, Balys MM, Pan L, Jacob S, Frontier A, Grever MR, Lucas DM, Kinghorn AD, Liesveld JL, Becker MW, Jordan CT. Leukemia. 2014 Oct;28(10):1960-8. doi: 10.1038/leu.2014.93. Epub 2014 Feb 28. PubMed |
| Generation and Neuronal Differentiation of Patient-Specific Induced Pluripotent Stem Cells Derived from Niemann-Pick Type C1 Fibroblasts. Trilck M, Hubner R, Frech MJ. Methods Mol Biol. 2014 Dec 18. PubMed |
| Characterization of bipolar disorder patient-specific induced pluripotent stem cells from a family reveals neurodevelopmental and mRNA expression abnormalities. Madison JM, Zhou F, Nigam A, Hussain A, Barker DD, Nehme R, van der Ven K, Hsu J, Wolf P, Fleishman M, O'Dushlaine C, Rose S, Chambert K, Lau FH, Ahfeldt T, Rueckert EH, Sheridan SD, Fass DM, Nemesh J, Mullen TE, Daheron L, McCarroll S, Sklar P, Perlis RH, Haggarty SJ. Mol Psychiatry. 2015 Jun;20(6):703-17. doi: 10.1038/mp.2015.7. Epub 2015 Mar 3. PubMed |
| BET inhibition represses miR17-92 to drive BIM-initiated apoptosis of normal and transformed hematopoietic cells. Xu Z, Sharp PP, Yao Y, Segal D, Ang CH, Khaw SL, Aubrey BJ, Gong J, Kelly GL, Herold MJ, Strasser A, Roberts AW, Alexander WS, Burns CJ, Huang DC, Glaser SP. Leukemia. 2016 Jul;30(7):1531-41. doi: 10.1038/leu.2016.52. Epub 2016 Mar 8. PubMed |
| RSPO2 inhibition of RNF43 and ZNRF3 governs limb development independently of LGR4/5/6. Szenker-Ravi E, Altunoglu U, Leushacke M, Bosso-Lefevre C, Khatoo M, Thi Tran H, Naert T, Noelanders R, Hajamohideen A, Beneteau C, de Sousa SB, Karaman B, Latypova X, Basaran S, Yucel EB, Tan TT, Vlaminck L, Nayak SS, Shukla A, Girisha KM, Le Caignec C, Soshnikova N, Uyguner ZO, Vleminckx K, Barker N, Kayserili H, Reversade B. Nature. 2018 May;557(7706):564-569. doi: 10.1038/s41586-018-0118-y. Epub 2018 May 16. PubMed |
| Evaluating class III antiarrhythmic agents as novel MYC targeting drugs in ovarian cancer. Belur Nagaraj A, Joseph P, Kovalenko O, Wang Q, Xu R, DiFeo A. Gynecol Oncol. 2018 Dec;151(3):525-532. doi: 10.1016/j.ygyno.2018.09.019. Epub 2018 Oct 6. PubMed |
| Frizzled-7 Is Required for Wnt Signaling in Gastric Tumors with and Without Apc Mutations. Flanagan DJ, Barker N, Costanzo NSD, Mason EA, Gurney A, Meniel VS, Koushyar S, Austin CR, Ernst M, Pearson HB, Boussioutas A, Clevers H, Phesse TJ, Vincan E. Cancer Res. 2019 Mar 1;79(5):970-981. doi: 10.1158/0008-5472.CAN-18-2095. Epub 2019 Jan 8. PubMed |
| REST and Neural Gene Network Dysregulation in iPSC Models of Alzheimer's Disease. Meyer K, Feldman HM, Lu T, Drake D, Lim ET, Ling KH, Bishop NA, Pan Y, Seo J, Lin YT, Su SC, Church GM, Tsai LH, Yankner BA. Cell Rep. 2019 Jan 29;26(5):1112-1127.e9. doi: 10.1016/j.celrep.2019.01.023. PubMed |
| Stage-specific requirement for Mettl3-dependent m(6)A mRNA methylation during haematopoietic stem cell differentiation. Lee H, Bao S, Qian Y, Geula S, Leslie J, Zhang C, Hanna JH, Ding L. Nat Cell Biol. 2019 Jun;21(6):700-709. doi: 10.1038/s41556-019-0318-1. Epub 2019 May 6. PubMed |
| Protein targeting chimeric molecules specific for dual bromodomain 4 (BRD4) and Polo-like kinase 1 (PLK1) proteins in acute myeloid leukemia cells. Mu X, Bai L, Xu Y, Wang J, Lu H. Biochem Biophys Res Commun. 2020 Jan 22;521(4):833-839. doi: 10.1016/j.bbrc.2019.11.007. Epub 2019 Nov 7. PubMed |
| Protein phosphatase 2A activation as a therapeutic strategy for managing MYC-driven cancers. Farrington CC, Yuan E, Mazhar S, Izadmehr S, Hurst L, Allen-Petersen BL, Janghorban M, Chung E, Wolczanski G, Galsky M, Sears R, Sangodkar J, Narla G. J Biol Chem. 2020 Jan 17;295(3):757-770. doi: 10.1074/jbc.RA119.011443. Epub 2019 Dec 10. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.